{"product_id":"clinical-genomic-interpretation-bioinformatics-and-ai-markets","title":"Clinical Genomic Interpretation, Bioinformatics and AI Markets 2027–2031","description":"\u003cp\u003e\u003cstrong\u003eClinical Genomic Interpretation, Bioinformatics and AI Markets: Market Forecast, Competitive Landscape, Company Revenue Estimates, Technology and World Metropolitan Area Market Sizes, 2027–2031\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlobal forecasts of clinical genomic interpretation, bioinformatics and AI revenue by product, technology, application, deployment and customer, for 14 countries and regions and 237 metropolitan areas, with 38 company profiles. Variant interpretation and clinical decision software, secondary analysis and pipelines, interpretation and curation services, genomic data platforms and cloud, and knowledge bases and content licences.\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_1126_Table_of_Contents.pdf?v=1793925146\" title=\"Clinical Genomic Interpretation, Bioinformatics and AI Markets Table of Contents\" target=\"_blank\" rel=\"noopener\"\u003eTable of Contents\u003c\/a\u003e. GET the \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Free sample\"\u003eFree Sample of this Report\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003eMany organizations subscribe to all or some of our reports. You may already have free access to this report. FIND out \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Contact Us\"\u003eHere\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eOur Take\u003c\/h3\u003e\n\u003cp\u003eEvery genomic test ends with an interpretation. The software, data and services that turn raw sequence reads into a signed clinical report grow far faster than sequencing itself, because test volumes rise, panels become exomes and genomes, and the costly step moves from the sequencer to the scientist reviewing variants. AI is joining that work, and interpretation is moving to the cloud. The market grows from $980.0 million in 2026 to $1,850.0 million in 2031, at 13.6% a year.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_Key_Graphic.png?v=1793925145\" alt=\"AI joins the interpretation: clinical genomic interpretation market by technology, 2026–2031\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMarket Size 2026:\u003c\/strong\u003e USD $980.0M   \u003cstrong\u003eMarket Size 2031:\u003c\/strong\u003e USD $1,850.0M   \u003cstrong\u003eCAGR:\u003c\/strong\u003e 13.6%\u003c\/p\u003e\n\u003ch3\u003eSituation Analysis: what is really happening\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAI joins the interpretation. \u003c\/strong\u003eGenerative AI \u0026amp; Large Language Models are the fastest-growing line at 42.6% a year, from 4.0% to 12.5% of the market, and Machine Learning Classifiers grow 17.6%, while Rules-Based \u0026amp; Curated Knowledge remains the foundation at 39.5% of the market in 2031.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInterpretation moves to the cloud. \u003c\/strong\u003eCloud \/ SaaS grows 17.4% a year, from 44.0% to 52.0% of the market, while On-Premise \u0026amp; Instrument-Embedded software grows 5.8% and falls from 27.0% to 19.0%.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInterpretation software leads. \u003c\/strong\u003eVariant Interpretation \u0026amp; Clinical Decision Software is the largest product line, rising from 34.0% to 36.0% of the market, and Genomic Data Platforms \u0026amp; Cloud is the fastest-growing at 15.8%, while Secondary Analysis \u0026amp; Pipelines grows 10.2% as analysis is bundled with sequencers or given away.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOncology is the core. \u003c\/strong\u003eOncology \u0026amp; Tumour Profiling is 47.0% of the market in 2026, and Pharmacogenomics is the fastest-growing application at 15.4% a year.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHospitals bring interpretation in house. \u003c\/strong\u003eHospital \u0026amp; Health System Labs grow 14.9% a year to 35.0% of the market, while Reference \u0026amp; Commercial Genomic Labs grow 11.3% as the largest laboratories build their own tools.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNew owners and new tools. \u003c\/strong\u003eEQT announced an offer that would take QIAGEN private, Illumina launched its BioInsight platform and DRAGEN Ultra, GeneDx acquired Fabric Genomics, SeqOne agreed to acquire Congenica, and BGI-Research and Zhejiang Lab open-sourced the Genos genomic foundation model. China is the fastest-growing country, at $70.3 million in 2026 and 20.7% a year.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_Cloud_Shift.png?v=1793925146\" alt=\"Interpretation moves to the cloud: clinical genomic interpretation market by deployment, 2026 vs 2031\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003ch3\u003eCompany Analysis: who is positioned, who is exposed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAgilent Technologies, Bio-Rad Laboratories, Illumina, MGI Tech \/ BGI Group, Oxford Nanopore Technologies, QIAGEN (QIAGEN Digital Insights), Roche and Thermo Fisher Scientific: \u003c\/strong\u003eSequencing, PCR and diagnostics companies, with HSR’s estimates of in-scope revenue and ranges.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e3billion, Euformatics, Fabric Genomics (GeneDx), Genomenon, Golden Helix, Limbus Medical Technologies (varvis), NGeneBio, PhenoTips, Saphetor (VarSome), SeqOne, SOPHiA GENETICS, Strand Life Sciences and Velsera: \u003c\/strong\u003eInterpretation software and service specialists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenXys Health Care Systems, InformedDNA (Coriell Life Sciences) and Translational Software: \u003c\/strong\u003ePharmacogenomic decision support.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAmazon Web Services, BC Platforms, DNAnexus, Google Cloud, Lifebit, Microsoft and NVIDIA: \u003c\/strong\u003eGenomic data platforms, cloud and acceleration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllelica, Caris Life Sciences, Genomics and Tempus AI: \u003c\/strong\u003eClinico-genomic data and polygenic risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ebioMérieux, One Codex and Ridom (Bruker): \u003c\/strong\u003eInfectious disease and microbial genomics software.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn all, 38 company profiles, each one to two pages with a fact box covering website, headquarters, ownership, revenue, employees and key products.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInside the report:\u003c\/strong\u003e HSR’s revenue estimate for every named company, with low–high ranges, and a growth and share-change map of every product and deployment line. Names and values are in the full report.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_Teaser_Company_Revenue.png?v=1793925146\" alt=\"Company revenue estimates, anonymised preview: names and values in the full report\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_Teaser_Segment_Map.png?v=1793925146\" alt=\"Growth and share-change map, anonymised preview: labels in the full report\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003ch3\u003eQuestions this report answers\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHow large is the clinical genomic interpretation, bioinformatics and AI market, and how fast will it grow?\u003c\/li\u003e\n\u003cli\u003eHow much in-scope revenue do Illumina, SOPHiA GENETICS, QIAGEN, Tempus, Velsera and other suppliers earn?\u003c\/li\u003e\n\u003cli\u003eHow fast are machine learning and generative AI changing variant interpretation, and what does open-source AI mean for prices?\u003c\/li\u003e\n\u003cli\u003eHow quickly is interpretation moving to the cloud, and which applications grow fastest?\u003c\/li\u003e\n\u003cli\u003eWhat do FDA, EU IVDR and AI Act, GDPR and China data rules mean for suppliers?\u003c\/li\u003e\n\u003cli\u003eHow large is each country market, and which metropolitan areas lead?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat's inside\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e418 pages, 23 chapters, 131 tables and 59 figures\u003c\/li\u003e\n\u003cli\u003eForecasts for 2027–2031 from a 2026 base year, by product, technology, application, deployment and customer, for 14 countries and regions\u003c\/li\u003e\n\u003cli\u003eMarket sizes for 237 world metropolitan areas in 2026 and 2031, with the top 30 and fastest-growing metros\u003c\/li\u003e\n\u003cli\u003eHow clinical genomic interpretation works; products, technologies, applications, deployment models and customers; technology trends; IVD – The Big Picture\u003c\/li\u003e\n\u003cli\u003eRegulation, data and quality; 10 market-moving developments; competitive landscape with company revenue estimates, SWOT, Porter's Five Forces and strategic recommendations\u003c\/li\u003e\n\u003cli\u003e38 company profiles\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_1126_Table_of_Contents.pdf?v=1793925146\" target=\"_blank\" rel=\"noopener\"\u003eDownload the Table of Contents (PDF)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho buys this report\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenomic software and AI companies: \u003c\/strong\u003esize target segments by product, technology, application and deployment, and benchmark competitors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequencing and diagnostics companies: \u003c\/strong\u003eplan informatics, AI and partnership strategies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical laboratories and health systems: \u003c\/strong\u003eplan build-versus-buy and the move to the cloud.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInvestors: \u003c\/strong\u003eassess consolidation, new owners and growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eUse independent research that makes you the expert. Your credit card order sends the report to your inbox instantly. Check all your licensing options, but don't worry: your order is available as a credit if you wish to upgrade.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_1126_Table_of_Contents.pdf?v=1793925146\" title=\"Clinical Genomic Interpretation, Bioinformatics and AI Markets Table of Contents\" target=\"_blank\" rel=\"noopener\"\u003eTable of Contents\u003c\/a\u003e. GET the \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Free sample\"\u003eFree Sample of this Report\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eABOUT THE LEAD AUTHOR\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg height=\"177\" width=\"142\" alt=\"Greg Powell\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/Powellcopy_480x480.png?v=1709168834\"\u003e\u003c\/p\u003e\n\u003cp\u003eMr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. His education includes:\u003c\/p\u003e\n\u003cp\u003eFinance for Senior Executives - \u003cstrong\u003eHarvard Business School\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMarket Research - \u003cstrong\u003eBurke Institute\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eM.B.A. (Finance and Policy) - \u003cstrong\u003eUniversity of British Columbia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eB.Sc. (Chemistry) - \u003cstrong\u003eUniversity of British Columbia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHe is an experienced business and clinical professional. He is co-author of the paper \"The Radioimmunoassay of Angiotensinogen by Antibody Trapping.\" He has worked in laboratory testing and management for over 20 years.\u003c\/p\u003e","brand":"Howe Sound Research","offers":[{"title":"Entire Report Single User","offer_id":68359789019249,"sku":null,"price":6995.0,"currency_code":"USD","in_stock":true},{"title":"Entire Report One to Five Users","offer_id":68359789052017,"sku":null,"price":9995.0,"currency_code":"USD","in_stock":true},{"title":"Entire Report Enterprise License","offer_id":68359789084785,"sku":null,"price":13995.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHGENAI_1126_covercap.png?v=1793925146","url":"https:\/\/www.howesoundresearch.com\/products\/clinical-genomic-interpretation-bioinformatics-and-ai-markets","provider":"Howe Sound Research","version":"1.0","type":"link"}